Synopsis of recent research by authors named "Maja de Jonge"
- Maja de Jonge's recent research emphasizes the exploration of targeted therapies and immunotherapy approaches in various cancer types, with particular focus on MET mutations in non-small-cell lung cancer and mismatch repair deficiencies in advanced solid tumors.
- Her studies showcase significant findings from phase 2 trials, including the effectiveness of therapies such as capmatinib, nivolumab, and olaparib, as well as the importance of biomarker analyses to optimize treatment strategies.
- Additionally, de Jonge's work involves investigations into circulating tumor cells and cell-free DNA as potential biomarkers in metastatic melanoma, demonstrating a commitment to integrating precision medicine in cancer treatment.
